To directly assess the impact of MIC-1/GDF15 on prostate cancer growth, we assigned 60 TRAMP and 60 TRAMPfmsmic-1 mice at 4–6 weeks of age and culled them progressively throughout 8–33 weeks of age. Here, GDF15 is linked to prostate carcinoma.